soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Semaglutide cardiovascular outcomes align more

Under Bra - 195 - 225 Say farewell to bra bulges with this treatment

Wegovy pill (oral semaglutide) is the first and only FDA-approved GLP-1 pill for weight loss

In a Lira-related study, healthy male C57BL/6 rats were evenly divided into three groups, namely NC group, model control group (OC group), and Lira group

For example, in women, chronic cortisol elevation links to lower implantation rates in assisted reproduction

Hemoglobin A1c levels typically rise within weeks to months after discontinuing GLP-1 therapy, returning toward pre-treatment values

Livovsky DM, Azpiroz F (2021) Gastrointestinal Contributions to the Postprandial Experience